Pathogen: clinical or host-associated sample from ... - BioSample

Pathogen: clinical or host-associated sample from Proteus mirabilis

Identifiers: BioSample: SAMN04014997; Sample name: FDA-CDC-AR_0156; SRA: SRS1613995

Organism: Proteus mirabilis
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Morganellaceae; Proteus

Attributes

BioProject: PRJNA292902 Enterobacteriaceae Carbapenemase Diversity genome sequencing and assembly
Retrieve all samples from this project

Submission: Centers for Disease Control and Prevention, Brian Yoo; 2015-08-27

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Testing standard
amikacin	susceptible	==	8	mg/L	MIC	CLSI
amoxicillin-clavulanic acid	intermediate	==	16/8	mg/L	MIC	CLSI
ampicillin	resistant	>	32	mg/L	MIC	CLSI
ampicillin-sulbactam	susceptible	==	8/4	mg/L	MIC	CLSI
aztreonam	susceptible	<=	2	mg/L	MIC	CLSI
cefazolin	resistant	>	8	mg/L	MIC	CLSI
cefepime	susceptible	<=	0.5	mg/L	MIC	CLSI
cefotaxime	susceptible	<=	0.5	mg/L	MIC	CLSI
cefoxitin	susceptible	==	4	mg/L	MIC	CLSI
ceftazidime	susceptible	<=	1	mg/L	MIC	CLSI
ceftriaxone	resistant	<=	1	mg/L	MIC	CLSI
ciprofloxacin	resistant	==	8	mg/L	MIC	CLSI
colistin	not defined	>	8	mg/L	MIC	CLSI
doripenem	resistant	==	4	mg/L	MIC	CLSI
ertapenem	intermediate	==	1	mg/L	MIC	CLSI
gentamicin	susceptible	==	4	mg/L	MIC	CLSI
imipenem	resistant	==	16	mg/L	MIC	CLSI
levofloxacin	susceptible	==	2	mg/L	MIC	CLSI
meropenem	susceptible	==	0.5	mg/L	MIC	CLSI
piperacillin-tazobactam	susceptible	<=	4/4	mg/L	MIC	CLSI
polymyxin B	not defined	>	8	mg/L	MIC	CLSI
tetracycline	resistant	==	32	mg/L	MIC	CLSI
tigecycline	susceptible	==	1	mg/L	MIC	CLSI
tobramycin	resistant	>	16	mg/L	MIC	CLSI
trimethoprim-sulfamethoxazole	resistant	>	8/152	mg/L	MIC	CLSI